Revefenacin
0149
Phase 3 small_molecule completed
Quick answer
Revefenacin for Chronic Obstructive Pulmonary Disease, COPD is a Phase 3 program (small_molecule) at Theravance Biopharma with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Theravance Biopharma
- Indication
- Chronic Obstructive Pulmonary Disease, COPD
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed